312 (Aspirin, Butalbital, Caffeine and Codeine Phosphate aspirin 325 mg / butalbital 50 mg / caffeine 40 mg / codeine phosphate 30 mg)
Pill with imprint 312 is Purple / Yellow, Capsule-shape and has been identified as Aspirin, butalbital, caffeine and codeine phosphate aspirin 325 mg / butalbital 50 mg / caffeine 40 mg / codeine phosphate 30 mg. It is supplied by Mayne Pharma Inc..
Aspirin/butalbital/caffeine/codeine is used in the treatment of headache and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine/codeine aspirin 325 mg / butalbital 50 mg / caffeine 40 mg / codeine phosphate 30 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images for 312
- aspirin 325 mg / butalbital 50 mg / caffeine 40 mg / codeine phosphate 30 mg
- Purple / Yellow
- Prescription only
- Drug Class:
- Narcotic analgesic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 3 - Moderate abuse potential
- Labeler / Supplier:
- Mayne Pharma Inc.
- National Drug Code (NDC):
More about aspirin/butalbital/caffeine/codeine
- Aspirin/butalbital/caffeine/codeine Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 27 Reviews – Add your own review/rating
- Drug class: narcotic analgesic combinations
- Aspirin, butalbital, caffeine, and codeine
- Butalbital, Aspirin, Caffeine, and Codeine
- Butalbital, aspirin, caffeine, and codeine (Advanced Reading)
- Butalbital,Aspirin,Caffeine,Codeine (FDA)
- Butalbital, Aspirin, Caffeine, and Codeine (Wolters Kluwer)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.